Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...
This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.
Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...
Multiplex Assays Market to be Worth $6.80 Billion by 2031 - Exclusive Report by Meticulous Research®
REDDING, Calif., Aug. 6, 2024 /PRNewswire/ -- According to a new market research report titled, 'Multiplex Assays Market Size, Share, Forecast, & Trends Analysis by Type (Protein [Bead, Planar], ...
Multiplex qPCR is a popular area of interest for many assay developers. Thanks to distinct reporter dyes, multiple reactions can be combined into a single well, with each target detected independently ...
SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company® ...
Novel Immunoassay Platform for Evaluating Multiple Analytes with Minimal Sample Volume The quantitative analysis of cytokines and other analytes in plasma, serum, or cell lysate is becoming ...
New FluoroType® Mycobacteria PCR assay detects the mycobacteria complex and differentiates 32 clinically relevant mycobacteria species from culture, using LiquidArray® multiplex PCR technology* New ...
Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) with varying capacities to evade vaccine-induced immunity continue to emerge, the latest one being the B.1.1.529 ...
LISBON, Portugal--(BUSINESS WIRE)--At the 32 nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results